about
Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomasIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaThe molecular biology of WHO grade I astrocytomasEpigenetics and human disease: translating basic biology into clinical applicationsScreening genes crucial for pediatric pilocytic astrocytoma using weighted gene coexpression network analysis combined with methylation data analysis.Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.CpG island hypermethylation in human astrocytomasHormone therapy, DNA methylation and colon cancer.Methylation profiling identifies 2 groups of gliomas according to their tumorigenesisGenome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.Molecular alterations in glioblastoma: potential targets for immunotherapy.DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytomaBrain tumours: classification and genesDNA methylation biomarkers of cancer: moving toward clinical application.Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors.Personalized treatment strategies in glioblastoma: MGMT promoter methylation status.Epigenetic changes in gliomas.Epigenetic markers in human gliomas: prospects for therapeutic intervention.Association between response to primary treatments and MGMT status in glioblastoma.Expression of SPRR3 is associated with tumor cell proliferation and invasion in glioblastoma multiforme.Molecular epigenetics and genetics in neuro-oncology.Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Deregulated chromatin remodeling in the pathobiology of brain tumors.DNA methylation and cancer diagnosis.Epigenetics in NG2 glia cells.In Silico Enhanced Restriction Enzyme Based Methylation Analysis of the Human Glioblastoma Genome Using Agilent 244K CpG Island Microarrays.HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy.Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric GlioblastomasBeyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic EventsHit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors.Estimation of a significance threshold for epigenome-wide association studies.Specific combinations of the chromatin-modifying enzyme modulators significantly attenuate glioblastoma cell proliferation and viability while exerting minimal effect on normal adult stem cells growth.Oligonucleotide DNA chips are useful adjuncts in epigenetic studies of glioblastomas.F10 gene hypomethylation, a putative biomarker for glioma prognosis.Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.
P2860
Q24550860-D1311527-D00D-4DFB-9833-5B5493BA6B99Q24612429-0753FC51-E60C-467D-AC29-2B5731E6B380Q27010414-A1002573-5372-48CF-8D2A-AECD1D7AA729Q28768502-0C77522F-C287-4A59-8B7C-0B3C49EECBDAQ30855264-78B60683-4EBE-46F7-89B4-807B0373E80EQ30887798-BA70AB3A-94EE-4822-B9F5-97E10689ED32Q33766932-105D81A2-2B8F-4A31-A984-A9190681246CQ33884570-B48DD23E-C5F1-4A52-A8AE-CA27C73B00CAQ34480513-19C2AB3E-E9AB-4590-A9B4-82F5E923E86AQ34511715-C0E8B56D-6EF9-4887-A9D6-5EAA4F983750Q34722434-F08B8DD5-B858-435E-8327-03159510727BQ34870511-051BEC9A-DF79-411B-8C92-C8F464109AB3Q35125867-845EA406-4801-438E-BC0F-4EA7B551F9BFQ35576526-523F3BA3-156A-4CC4-A593-7621A8BADE86Q35873699-CA77B003-4C5D-41B2-9D33-CF5590DC6D4AQ35945177-91AC932E-F882-48FE-AAB1-E54C5A60CAA5Q36284970-B448673A-D4A2-44FD-9A15-F5F41BEF5B62Q36288237-1CEC9DF7-EFA6-42EB-9A17-11B95070A557Q37148924-A48CB557-B24D-46B9-AF7D-1A91D63758F7Q37221207-AD25C90C-9813-451A-818A-E619529540D9Q37287032-C3930E04-E630-48E4-9425-A48207FB9962Q37301207-F71C072E-5A5F-486F-BA59-21B9488F043AQ37316991-081FB955-49AF-48B4-AF2A-99058021B69AQ37438054-02A7A41A-DFFF-4784-B571-2F7D338A575DQ37533620-0B97EA70-C619-45BC-AA0C-CB02C77BBC34Q37937061-9E131C5D-EFFD-4351-AB6A-73720923AA2BQ38024560-07337BFA-25CD-43FF-AB1E-9E82339F26DBQ38056842-EBB0B5B9-94F6-4ADA-85E3-8726EC4FBA9AQ38123094-3546DE7E-3BFB-44B9-A35F-EF98FF5E0DFBQ38532591-D9BF263D-C48A-4418-9EFB-F5D69512CD39Q40156702-EF9451AF-D8D6-4815-AC18-8E7B5178A5D0Q40250355-183DCA5E-952A-41DB-8CD1-D5233D4FD4FAQ40580350-BECA472C-339D-4E09-AE6D-BB989ED373AFQ41896356-B3447175-354C-4A58-A19B-0DEAD9C0BD4FQ44573227-F173D895-106E-4636-8FC7-A53D505AE44EQ46263944-704320F4-54EC-490A-BB6B-D88D9526211FQ48124054-9E9E1F5B-1116-4A79-8FC1-0711B92F1435Q48380492-F1E8E604-730B-4BB4-A41B-3CF51B42CED1Q48786544-91422C2C-8EBA-4ABF-9F52-0E4991BB81DDQ49645086-5408A58C-21FA-4C65-A129-3812652CAAE8
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Distinct methylation profiles of glioma subtypes.
@en
Distinct methylation profiles of glioma subtypes.
@nl
type
label
Distinct methylation profiles of glioma subtypes.
@en
Distinct methylation profiles of glioma subtypes.
@nl
prefLabel
Distinct methylation profiles of glioma subtypes.
@en
Distinct methylation profiles of glioma subtypes.
@nl
P2093
P2860
P356
P1476
Distinct methylation profiles of glioma subtypes.
@en
P2093
Constanze Zeller
Gundula Thiel
Janusz Szymas
Karen Uhlmann
Karola Marczinek
Klaus Rohde
Peter W Laird
Siegfried Vogel
P2860
P356
10.1002/IJC.11175
P577
2003-08-01T00:00:00Z